Prevention and therapy of thromboembolic complications with dextran.
D000227:Adenine Nucleotides / Q000494:pharmacology; D000818:Animals; D001158:Arteries / Q000601:surgery; D001791:Blood Platelet Disorders / Q000139:chemically induced; D002417:Cattle; D003238:Connective Tissue; D003911:Dextrans / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004285:Dogs; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006168:Guinea Pigs; D006487:Hemostasis; D007263:Infusions, Parenteral; D008970:Molecular Weight; D011183:Postoperative Complications / Q000517:prevention & control; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D012756:Sheep; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000188:drug therapy / Q000517:prevention & control; D013927:Thrombosis / Q000150:complications / Q000517:prevention & control; D014020:Tissue Extracts; D014465:Ultrasonics
D000227:Adenine Nucleotides; D003911:Dextrans; D005343:Fibrinolytic Agents; D014020:Tissue Extracts; D012701:Serotonin